InsidersTradesSigma
Track the 博瑞医药 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 博瑞医药 has recorded 1 reports. Market capitalisation: €14.5bn. The latest transaction was filed on 18 November 2024 (Purchase). Among the most active insiders: 程增江. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
博瑞医药 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative drugs.